These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9000593

  • 21. Generation and characterization of a human osteosarcoma cell line stably transfected with the human estrogen receptor gene.
    Huo B, Dossing DA, Dimuzio MT.
    J Bone Miner Res; 1995 May; 10(5):769-81. PubMed ID: 7639112
    [Abstract] [Full Text] [Related]

  • 22. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
    Murphy CS, Pink JJ, Jordan VC.
    Cancer Res; 1990 Nov 15; 50(22):7285-92. PubMed ID: 2224859
    [Abstract] [Full Text] [Related]

  • 23. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM, Colston K, Jiang WG, Sharma AK, Mokbel K.
    Breast Cancer Res Treat; 2006 Oct 15; 99(3):275-88. PubMed ID: 16752221
    [Abstract] [Full Text] [Related]

  • 24. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A, Bouclier C, Marsaud V, Maillard S, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2005 Feb 15; 94(1-3):71-81. PubMed ID: 15862952
    [Abstract] [Full Text] [Related]

  • 25. T47DCO cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance.
    Graham ML, Krett NL, Miller LA, Leslie KK, Gordon DF, Wood WM, Wei LL, Horwitz KB.
    Cancer Res; 1990 Oct 01; 50(19):6208-17. PubMed ID: 2400987
    [Abstract] [Full Text] [Related]

  • 26. The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain.
    Wolf DM, Jordan VC.
    Breast Cancer Res Treat; 1994 Oct 01; 31(1):129-38. PubMed ID: 7981453
    [Abstract] [Full Text] [Related]

  • 27. Estradiol regulation of the human retinoic acid receptor alpha gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs.
    Rishi AK, Shao ZM, Baumann RG, Li XS, Sheikh MS, Kimura S, Bashirelahi N, Fontana JA.
    Cancer Res; 1995 Nov 01; 55(21):4999-5006. PubMed ID: 7585542
    [Abstract] [Full Text] [Related]

  • 28. Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.
    Hutcheson IR, Knowlden JM, Madden TA, Barrow D, Gee JM, Wakeling AE, Nicholson RI.
    Breast Cancer Res Treat; 2003 Sep 01; 81(1):81-93. PubMed ID: 14531500
    [Abstract] [Full Text] [Related]

  • 29. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 30. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R, Young PC, Caperell-Grant A, Gize EA, Madhukar BV, Ben-Jonathan N, Bigsby RM.
    Cancer Res; 1996 Dec 01; 56(23):5403-9. PubMed ID: 8968093
    [Abstract] [Full Text] [Related]

  • 31. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
    Ramamoorthy K, Wang F, Chen IC, Norris JD, McDonnell DP, Leonard LS, Gaido KW, Bocchinfuso WP, Korach KS, Safe S.
    Endocrinology; 1997 Apr 01; 138(4):1520-7. PubMed ID: 9075711
    [Abstract] [Full Text] [Related]

  • 32. Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.
    Newman SP, Bates NP, Vernimmen D, Parker MG, Hurst HC.
    Oncogene; 2000 Jan 27; 19(4):490-7. PubMed ID: 10698518
    [Abstract] [Full Text] [Related]

  • 33. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line.
    Castles CG, Fuqua SA, Klotz DM, Hill SM.
    Cancer Res; 1993 Dec 15; 53(24):5934-9. PubMed ID: 8261406
    [Abstract] [Full Text] [Related]

  • 34. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells.
    Chien PY, Ito M, Park Y, Tagami T, Gehm BD, Jameson JL.
    Mol Endocrinol; 1999 Dec 15; 13(12):2122-36. PubMed ID: 10598586
    [Abstract] [Full Text] [Related]

  • 35. Methylation of CpG island is not a ubiquitous mechanism for the loss of oestrogen receptor in breast cancer cells.
    Chen Z, Ko A, Yang J, Jordan VC.
    Br J Cancer; 1998 Dec 15; 77(2):181-5. PubMed ID: 9460986
    [Abstract] [Full Text] [Related]

  • 36. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
    Philips A, Teyssier C, Galtier F, Rivier-Covas C, Rey JM, Rochefort H, Chalbos D.
    Mol Endocrinol; 1998 Jul 15; 12(7):973-85. PubMed ID: 9658402
    [Abstract] [Full Text] [Related]

  • 37. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines.
    Pfeffer U, Fecarotta E, Castagnetta L, Vidali G.
    Cancer Res; 1993 Feb 15; 53(4):741-3. PubMed ID: 7916651
    [Abstract] [Full Text] [Related]

  • 38. Identification and characterization of estrogen receptor variants in prostate cancer cell lines.
    Ye Q, Chung LW, Cinar B, Li S, Zhau HE.
    J Steroid Biochem Mol Biol; 2000 Dec 01; 75(1):21-31. PubMed ID: 11179905
    [Abstract] [Full Text] [Related]

  • 39. The 90 kDa heat-shock protein (hsp90) modulates the binding of the oestrogen receptor to its cognate DNA.
    Sabbah M, Radanyi C, Redeuilh G, Baulieu EE.
    Biochem J; 1996 Feb 15; 314 ( Pt 1)(Pt 1):205-13. PubMed ID: 8660284
    [Abstract] [Full Text] [Related]

  • 40. Identification of an enhancer element in the estrogen receptor upstream region: implications for regulation of ER transcription in breast cancer.
    Cohn CS, Sullivan JA, Kiefer T, Hill SM.
    Mol Cell Endocrinol; 1999 Dec 20; 158(1-2):25-36. PubMed ID: 10630402
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.